NZ's AFT Pharmaceuticals gains on deal to distribute pain management tablets in US

AFT Pharmaceuticals

08/08/2024 03:20

** Shares of AFT Pharmaceuticals  AFT.NZ  rise as much as
1.6% to NZ$3.15, their highest level since June 18
    ** Pharmaceutical co signs agreement with Hikma
Pharmaceuticals USA to distribute its patented COMBOGESIC
tablets, used for adult pain management, to select markets in
the United States
    ** Adds, the agreement furthers the cooperation between the
companies after the April 2021 agreement for the intravenous
form, COMBOGESIC IV, and will cover market segments where the IV
dose form will be used such as hospitals and ambulatory surgical
centres
    ** Stock has fallen 11.4% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))